Published in World J Cardiol on January 26, 2016
12-lead electrocardiogram features of arrhythmic risk: A focus on early repolarization. World J Cardiol (2016) 0.75
Drug-induced prolongation of the QT interval. N Engl J Med (2004) 10.96
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J (1957) 5.29
THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES. Can Med Assoc J (1963) 5.03
Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation (1999) 4.51
What clinicians should know about the QT interval. JAMA (2003) 4.45
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J (1990) 4.28
Short QT Syndrome: a familial cause of sudden death. Circulation (2003) 4.23
Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation (1998) 4.13
Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med (1994) 4.00
Torsades de pointes occurring in association with terfenadine use. JAMA (1990) 3.93
Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation (2003) 3.68
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation (1991) 3.25
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA (1993) 3.01
NONUNIFORM RECOVERY OF EXCITABILITY IN VENTRICULAR MUSCLE. Circ Res (1964) 2.92
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation (1988) 2.86
Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 2.85
Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry (2011) 2.75
Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation (2003) 2.75
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation (1983) 2.74
Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry (2002) 2.69
The measurement of the Q-T interval of the electrocardiogram. Circulation (1952) 2.68
Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol (2001) 2.55
Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation (1997) 2.53
Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol (2007) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation (2009) 2.31
Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol (1998) 2.25
Importance of lead selection in QT interval measurement. Am J Cardiol (1988) 2.23
The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol (2009) 2.22
Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs (2002) 2.09
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm (2005) 2.07
New echocardiographic insights in short QT syndrome: More than a channelopathy? Heart Rhythm (2015) 2.05
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation (1996) 2.04
Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J (1975) 2.03
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace (2013) 1.97
Genetics of acquired long QT syndrome. J Clin Invest (2005) 1.96
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation (1987) 1.81
Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol (2003) 1.81
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78
QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J (1992) 1.70
Long QT Syndrome. Curr Probl Cardiol (2008) 1.70
Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol (2006) 1.68
QT dispersion. Br Heart J (1994) 1.62
Risk prediction of cardiovascular death based on the QTc interval: evaluating age and gender differences in a large primary care population. Eur Heart J (2014) 1.60
QT dynamics in risk stratification after myocardial infarction. Heart Rhythm (2005) 1.59
Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. Circulation (2000) 1.58
QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol (2003) 1.56
Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol (2005) 1.56
QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart (2007) 1.55
Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2007) 1.55
Common standards for quantitative electrocardiography: goals and main results. CSE Working Party. Methods Inf Med (1990) 1.54
QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure: analysis of Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Heart Rhythm (2011) 1.52
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47
Errors in manual measurement of QT intervals. Br Heart J (1994) 1.47
Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. Am Heart J (2012) 1.46
Ischaemia induced alternans of action potential duration in the intact-heart: dependence on coronary flow, preload and cycle length. Eur Heart J (1993) 1.46
The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J (1977) 1.44
QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol (2004) 1.43
Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol (1994) 1.43
QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. Eur Heart J (2006) 1.39
Premature beats elicit a phase reversal of mechanoelectrical alternans in cat ventricular myocytes. A possible mechanism for reentrant arrhythmias. Circulation (1995) 1.37
Electrophysiological alternans and restitution during acute regional ischaemia in myocardium of anaesthetized pig. J Physiol (1988) 1.35
Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation (1978) 1.35
Dispersion of ventricular repolarization: reality? Illusion? Significance? Circulation (1998) 1.32
Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation (2002) 1.30
Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol (2007) 1.29
Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis. Circ Arrhythm Electrophysiol (2009) 1.29
QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation (2011) 1.28
The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920. Ann Noninvasive Electrocardiol (2003) 1.25
Measurement of the QT interval. Eur Heart J (1985) 1.25
Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation (2001) 1.22
Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med (2005) 1.22
Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. Am J Cardiol (1991) 1.20
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol (2006) 1.19
Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2. Circ Cardiovasc Genet (2015) 1.19
Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry (2008) 1.19
Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation (1978) 1.18
Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic. Int J Clin Pract (2010) 1.18
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet (2014) 1.17
Structure and function of carbonic anhydrases. Imidazole binding to human carbonic anhydrase B and the mechanism of action of carbonic anhydrases. FEBS Lett (1977) 1.15
Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study. Am J Psychiatry (2013) 1.13
Genetic and clinical advances in congenital long QT syndrome. Circ J (2014) 1.12
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J (2011) 1.11
QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev (2002) 1.10
Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac death. Circ Arrhythm Electrophysiol (2012) 1.09
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin (2013) 1.09
Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms. Pacing Clin Electrophysiol (1999) 1.09
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry (2005) 1.08
Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J (1985) 1.08